key: cord-1004332-e4eew7ha authors: Barr, Frances title: SCIENTIFIC INFORMATION DOCUMENT Feline infectious peritonitis date: 2008-06-28 journal: J Small Anim Pract DOI: 10.1111/j.1748-5827.1998.tb03691.x sha: 562790c9238a8cac4c9ad74409241cb97d6ae79a doc_id: 1004332 cord_uid: e4eew7ha nan feline coronavirus (FCoV). Historically, FIP was considered to be caused by FIP virus (FIPV) and feline enteritis by a feline enteric coronavirus (FECV). Recent studies have shown that there is essentially only one FCoV in the field, although laboratory strains may vary in virulence. genomic studies have failed to show a consistent mutation distinguishing FIP strains from FECV strains. Nevertheless, it is believed that a mutation in the virus alters its cell tropism from enteric epithelial cells to macrophages, resulting in FIP Alternatively, since FIP usually follows an episode of stress (rehoming, surgery, kittening and so on), it is possible that disease is related to virus dose and a non-protective immune response. FCoVs are serologically related to canine coronavirus (CCV), transmissible gastroenteritis virus of pigs, porcine epidemic diarrhoea virus and human bronchitis virus 229-E, and belong to one of two distinct serotypes; most field infections are caused by serotype I FCoV, whereas most laboratory isolates are type II. Serotype I1 isolates evolved more recently than serotype I through recombination between type I FCoV and CCV. The role of CCV in causing FIP is unclear, although McArdle and others (1992) have shown that CCV administered parenterally to cats will cause FIP-like disease. All cats are susceptible to FIE but the disease is seen primarily in cats aged between three months and two years old, with a second peak in cats over 10 years of age, possibly associated with a decline in immune responses. Kittens are protected from FCoV by maternal antibodies up to approximately six weeks of age. FCoV is very infectious. Over 90 per cent of cats exposed to it will seroconvert and, of these, approximately 10 per cent will develop signs of FIE? The seroprevalence of FCoV is approximately 25 per cent in singlecat households and up to 100 per cent in multicat households in which the virus is endemic. Approximately half the cat breeders in the UK are thought to have FCoV endemic among their cats, compared with only about a quarter of multicat households where the cats are kept simply as pets. The main predisposing factors to FIP in multicat groups are greater environmental virus levels with consequent higher infective doses and increased stress levels which may reduce immunity. FCoV is shed in the faeces and transmission occurs mainly via the sharing of litter trays with an infected cat. Horizontal transmission (direct cat-to-cat infection) can occur, although virus is shed in the saliva for only about one month after infection. The virus is fragile and can be destroyed by household disinfectants, particularly sodium hypochlorite (bleach). However, some strains can survive for up to seven weeks in the environment and thus fomite transmission is a real risk in specific pathogen-free, rescue and breeding catteries. Transmission on clothing from house to house (for example, by a visiting veterinary surgeon) is extremely unlikely unless clothing is contaminated with particulate faeces. Transplacental transmission, although rare, has been documented. The incidence of feline leukaemia virus has been shown to be no higher in cats which develop FIP than in the general cat population and the incidence of feline immunodeficiency virus even less. In 90 per cent of infected cats, FCoVs infect the intestinal epithelial cells causing a mild or asymptomatic enteritis and, in at least 25 per cent of these, virus can also be detected in blood. Most of these infected cats will mount a successful immune response and sliminate the virus, although a few will remain healthy carriers. In the remaining 10 per cent of infected cats disseminated vasculitis ensues. Vasculitis may occur because virus-infected macrophages leave small blood vessels and an inflammatory response develops around them, or because circulating immune complexes attract an inflammatory response. A pyogranuloma develops around the blood vessel and the blood supply to the organ is affected. In effusive ('wet') FIE many blood vessels are affected and a protein-rich exudate of the same composition as plasma leaks out into the body cavities. In non-effusive ('dry') FIP, only a few blood vessels are affected and the body attempts to 'wall off' the lesions by forming pyogranulomata which may become quite large (up to 2 cm). One theory is that non-effusive FIP occurs where there has been a partially successfd cell-mediated immune response. The course of non-effusive FIP is much more chronic, with the cat being ill for weeks to months. In some cases, non-effusive FIP may develop into the effusive form terminally. FCoV in the gastrointestinal tract may cause a mild pyrexia, small or large bowel diarrhoea and sometimes vomiting. Transient upper respiratory tract signs have been reported when FCoV first enters a cattery. These signs may be seen weeks or even months before the onset of the first case of FIE However, in the majority of FCoV infections no clinical signs are observed. FIP (effusive and non-effusive forms) is characterised by a lowgrade fever (39.0 to 39.5"C) unresponsive to antibacterial drugs, weight loss, anorexia and lethargy, and often a particularly palpable mesenteric lymph node. With the effusive form of FIP a high-protein exudate develops in the abdomen causing ascites and in around 25 per cent of these cases exudate also develops in the thorax, causing dyspnoea and tachypnoea. Entire male cats may show scrotal swelling. Vomiting and diarrhoea may also develop as a consequence of peritoneal inflammation. Non-effusive FIP is characterised by the development of granulomas in a variety of organs, including the liver, kidney, spleen, omentum, lymph nodes, lungs, eye and central nervous system. The ocular signs include anterior uveitis (hypopyon, hyphaemia, aqueous flare and miosis), retinal haemorrhage and linear retinal detachment. Up to 25 per cent of cats with non-efisive FIP eventually develop multifocal progressive neurological signs (eg, seizures, vertical or rotatory nystagnius, tremors, hyperaesthesia, changes in temperament and proprioceptive deficits). Haematological findings are variable and non-specific, and include a normocytic, normochromic, non-regenerative anaemia, neutrophilia and lymphopenia. Leucopenia may develop terminally. Serum biochemistry and urinalysis abnormalities relate to specific organ involvement; thus cats with renal involvement may show proteinuria, although azotaemia develops only in advanced disease. Hyperbilirubinaemia and elevated alanine transaminase and alkaline phosphatase concentrations reflect hepatic involvement. Hyperglobulinaemia is present in more than 50 per cent of cats with effusive FIP and 7 5 per cent with non-effusive FIP, and is a polyclonal garnmopathy. Analysis of cerebrospinal fluid in cats with non-effusive FIP demonstrates elevated protein concentrations and neutrophilic pleocytosis. Ehsions contain high protein concentrations due to protein leakage from plasma, are often yellow and contain fibrin clots, with nondegenerate neutrophils the predominant cell type. Serology can be performed on plasma, serum or effusion. Testing for FCoV antibodies is usually performed for one of the following reasons: A diagnosis of FIP Is suspected 0 Non-efisive FIJ? The anti-FCoV antibody titre should be 1280 or higher. A titre of less than 320 usually rules out noneffusive FIE Ocular lesions, an a1bumin:globulin ratio of less than 0-7 and alpha-1 acid glycoprotein (AGP) result ofgreater than 1500 mg/ml should also be present before making a diagnosis of FIE? Serology in these instances is usually carried out for one of the two reasons discussed below. In either case, make it clear to the owner before testing that it is very likely that the cat will be seropositive. Almost all cats exposed to FCoV become infected. Reassure the owner that this does not indicate a poor prognosis for the cat as approximately nine out of 10 cats infected with FCoV will not develop FIP and many will eventually become seronegative. The owner wishes to obtain another cat. If the cat is seronegative (ie, has an antibody titre of zero) it is not shedding virus and it is safe to get another cat. However, if the cat is seropositive (ie, has an antibody titre of 10 or over) there is a 1 in 3 chance that it is shedding FCoV so it would be unwise to get another cat (unless it also has antibodies), although cats with anti- Cat breeders often request that their cats be screened for FCoV before mating. If the cat is seronegative it is not excreting FCoV and can be mated safely. Be sure to find a seronegative mate for it. If the cat is seropositive it would be wise to find a seropositive mate so as not to risk introducing FCoV into a FCoV-free cattery. Kittens of such a mating should be prevented from becoming infected by isolation and early weaning (see below). If there are many cats mixing together, then a random sampling of three or four cats will determine whether FCoV is endemic (because FCoV is very contagious). Households of fewer than 10 cats and those where the cats are isolated from each other in groups of three or less often lose their FCoV infection eventually. Testing every six to 12 months will establish when this is occurring as antibody titres fall and an increasing proportion of cats becomes seronegative. The only safe antibody titre in this circumstance is zero. FCoV genome may be detected using RT-PCR technology. The genomes of the avirulent or enteritis-inducing laboratory strains of FCoV are indistinguishable from those of FIP-inducing strains. Thus it is not possible to determine whether a cat will or will not develop FIP using this test. Monitoring virus excretion. RT-PCR can also be used to detect FCoV in the faeces of cats which are shedding virus in households where shedders and non-shedders are being separated in an attempt to eliminate FCoV infection. Virus isolation can be attempted but is often unrewarding due to the difficulty in encouraging wild virus to adapt to cell culture. Work in this field is currently being undertaken at Bristol veterinary school. Histopathological examination of biopsy samples of lesions is the only absolutely conclusive method of making an antemortem diagnosis. Characteristically there are disseminated pyogranulomata around small blood vessels. In dubious lesions, immunohistochemisuy can be performed. With the exception of immunohistochemistry of a pyogranuloma, there is no one test or clinical finding that can diagnose FIP definitively. However, various studies have looked at combinations of indications and reported a high predictive value. These are summarised by McReynolds and Macy (1997) . For example, a cat with clinical signs consistent with FIE a lymphopenia, a FCoV titre of greater than 160 and a hyperglobulinaemia was found to have an 89 per cent probability of having FIP confirmed postmortem. If a cat showed signs of FIP but did not have all three of the above results, there was a 99 per cent probability that it did not have FII? Several studies have recently shown that protein electrophoresis may be of value in cats with appropriate clinical signs and other positive indicators. Gamma globulin levels in excess of 32 per cent of the IOURNAL OF SMALL ANIMAL PRACTlCE VOL 39 OCTOBER 1998 total protein content have a 100 per cent predictive value, while an albumin concentration greater than 48 per cent of the protein content has a I00 per cent negative predictive value (prevalence rate 2 1 per cent), thus ruling out the diagnosis. Treatment for cats suffering from FIP is symptomatic, with fluid replacement and nutritional support of paramount importance. I n view of the immunological nature of the disease, treatment with immunosuppressive doses of corticosteroids (2 to 4 mg prednisolone/kg/day) is a rational approach, along with broad spectrum antibiotics. There may be a place for immunosuppressive drugs such a5 cyclophosphamide, although no treatment has been shown to affect the clinical outcome. FIP is invariably fatal and euthanasia is thereforc a treatment option. FCoVs are difficult co control in niulticat environments due to: 0 the potentially long and unpredictable incubation period; the difficulty inherent in identi-Fying carriers which are shedding rhe virus; 0 the ability of FCoV to survive in the environment; 0 the infectious nature of the virus, which infects 36 to 100 per cent of in-contact cats. If FIP is confirmed in a cattery, the serological testing of other cats is useful if the owner requests a prognosis for these cats or wishes to add further stock. It must be emphasised at the outset that it is verv likely that most, or all, of the cats will be seropositive. This does nor necessarily indicate a poor prognosis as FIP is only likely to develop in 12 to 16 per cent of cats following initial exposure to the virus and in 3 to 4 per cent of cats which have encountered it at some time previously. A recent survey showed rhac over 33 per cent of seropositive cats will become seronegarive provided no new infection is introduced. This loss of antibody can take from three to 25 months, with approximately one-third of the cats becoming seronegative within one year. Housing of the cats has the biggest influence on whether they become seronegative. Those housed in groups of three cats or less are more likely to become seronegative than those housed in larger groups. Age, breed and gender have no influence on the loss of FCoV antibodies. Seronegative cats should not be introduced into seropositive catteries. Kittens and new cats should not be introduced into a cattery until the existing resident cats have become seronegative. To maintain a seronegative household, cats which have been to shows, or left the premises, should ideally be isolated on their return and antibody tested two weeks later. Approximately 1 in 3 seropositive queens excrete virus regardless of the antibody titre. To prevent infection of kittens from a seropositive queen, the queen should be isolated with her kittens from birth. The litter should be weaned at five weeks old (as protective maternal antibody wanes) and isolated from all other cats in the household, including their dam and the kittens from other litters. If possible, test the kittens at 10 to 12 weeks of age to ensure that they have not been infected. This method has been found to be completely effective in producing FCoV-free kittens. However, some breeders prefer to isolate seropositive queens and retest every six to 12 months until they become scronegative, before breeding again. Seropositive kittens have a 1 in 10 chance of developing FII? They can be rehomed where no other cats are present, and the owners warned of the 10 per cent chance of FIP, or they can be kept in total isolation and tested monthly until they either become seronegative or develop the disease. Seronegative queens can be left with their kittens indefinitely. An intranasal vaccine (Priniucell; Pfizer) has been launched in the USA and parts of Europe, providing encouragement for the control of FCoV. The vaccine causes seroconversion and stimulates mucosal and cell-mediated immunity. Its efficacy is around 50 to 75 per cent when used on cats which have not been exposed to FCoV. It is not yet available in the UK. Control of feline coronavirus infection in kittens I 992) A study of narurally occurring feline coronavirus infection in kittens Feline coronavirus in the inresrinal contents of cats with feline infectious peritonitis Placebo-controlled evaluation of a modified live virus vaccine against feline infectious peritonitis: safety and efficacy under ficld conditions 1005) Detection of coronavirus KNA in faeces, tissues and body fluids of naturally infcctcd cats by reverse transcriprase PCR Update of felinc infectious peritonitis Induction and enhancement of feline infectious peritonitis by canine coronavirus: a preliminary study Feline infectious peritonitis. Part 1, Etiology and diagnosis Feline infectious perironiris virus: advances in therapy and control The section on the uses of serology has been reproduced with kind permission from the Feline Virus Unit, University of Glasgow Veterinary School. The illustrations were supplied by Dr Bryn Tennant.